Efficacy of systematic catheter locks solution of taurolidine/heparin versus taurolidine/urokinase in end-stage renal insufficiency stage 5D

Saved in:
Bibliographic Details
Published in:Nefrología 2022-09, Vol.42 (5), p.611-613
Main Authors: Fontseré, Néstor, Soriano, Alex, Mestres, Gaspar, Bermudez, Patricia, Zarco, Federico, Lozano, Valentín, Rodas, Lida, Broseta, Jose, Arias, Marta, Maduell, Francisco
Format: Article
Language:English
Subjects:
Catheters
Heparin - adverse effects
Humans
Kidney Failure, Chronic - complications
Kidney Failure, Chronic - therapy
Urokinase-Type Plasminogen Activator
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c2683-8d51ee4ab78bebb07e7e4eaacb007ff4ef582a790d7b0ca81b410a1ff4a8ea393
container_end_page 613
container_issue 5
container_start_page 611
container_title Nefrología
container_volume 42
creator Fontseré, Néstor
Soriano, Alex
Mestres, Gaspar
Bermudez, Patricia
Zarco, Federico
Lozano, Valentín
Rodas, Lida
Broseta, Jose
Arias, Marta
Maduell, Francisco
description
doi_str_mv 10.1016/j.nefroe.2021.02.013
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_c643bc5115e54cf9ac335f0932f79725</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S201325142300007X</els_id><doaj_id>oai_doaj_org_article_c643bc5115e54cf9ac335f0932f79725</doaj_id><sourcerecordid>2768222894</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2683-8d51ee4ab78bebb07e7e4eaacb007ff4ef582a790d7b0ca81b410a1ff4a8ea393</originalsourceid><addsrcrecordid>eNp9UcFu1TAQjCoQLYU_qFCOXJLaThzHFyRUWqhUiQucrbWzbv2aFz-8SaX3D3x0_ZpSwYXTrnZmd7QzRXHGWc0Z78439YQ-RawFE7xmoma8OSpORC6VkLx99Vd_XLwl2jDWSaHVm-K46bpOaylOit-X3gcHbl9GX9KeZtzCHFzpYL7DGVM5RndPJcVxmUOcDqwZlhTHMIQJz-9wBylM5QMmWugfKHf3YQLCMuM4DRXNcItlwgnGPKLlIBxwytIrIr-8K157GAnfP9fT4ufV5Y-Lb9XN96_XF59vKie6vqn6QXLEFqzqLVrLFCpsEcBZxpT3LXrZC1CaDcoyBz23LWfAMwI9QqOb0-J6vTtE2JhdCltIexMhmKdBTLcGUnZhROO6trFOci5Rts5rcE0jPdON8EorIfOtj-utXYq_FqTZbAM5HEeYMC5khOp6IUSv20xtV6pLkSihf5HmzBwyNRuzZmoOmRomTA4wr314VljsFoeXpT8hZsKnlYDZs4eAydCTsTiEhG7OT4X_KzwCFC24MA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2768222894</pqid></control><display><type>article</type><title>Efficacy of systematic catheter locks solution of taurolidine/heparin versus taurolidine/urokinase in end-stage renal insufficiency stage 5D</title><source>ScienceDirect Freedom Collection</source><creator>Fontseré, Néstor ; Soriano, Alex ; Mestres, Gaspar ; Bermudez, Patricia ; Zarco, Federico ; Lozano, Valentín ; Rodas, Lida ; Broseta, Jose ; Arias, Marta ; Maduell, Francisco</creator><creatorcontrib>Fontseré, Néstor ; Soriano, Alex ; Mestres, Gaspar ; Bermudez, Patricia ; Zarco, Federico ; Lozano, Valentín ; Rodas, Lida ; Broseta, Jose ; Arias, Marta ; Maduell, Francisco</creatorcontrib><identifier>ISSN: 2013-2514</identifier><identifier>EISSN: 2013-2514</identifier><identifier>DOI: 10.1016/j.nefroe.2021.02.013</identifier><identifier>PMID: 36669952</identifier><language>eng</language><publisher>Spain: Elsevier España, S.L.U</publisher><subject>Catheters ; Heparin - adverse effects ; Humans ; Kidney Failure, Chronic - complications ; Kidney Failure, Chronic - therapy ; Urokinase-Type Plasminogen Activator</subject><ispartof>Nefrología, 2022-09, Vol.42 (5), p.611-613</ispartof><rights>2021 Sociedad Española de Nefrología</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2683-8d51ee4ab78bebb07e7e4eaacb007ff4ef582a790d7b0ca81b410a1ff4a8ea393</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S201325142300007X$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3549,27924,27925,45780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36669952$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fontseré, Néstor</creatorcontrib><creatorcontrib>Soriano, Alex</creatorcontrib><creatorcontrib>Mestres, Gaspar</creatorcontrib><creatorcontrib>Bermudez, Patricia</creatorcontrib><creatorcontrib>Zarco, Federico</creatorcontrib><creatorcontrib>Lozano, Valentín</creatorcontrib><creatorcontrib>Rodas, Lida</creatorcontrib><creatorcontrib>Broseta, Jose</creatorcontrib><creatorcontrib>Arias, Marta</creatorcontrib><creatorcontrib>Maduell, Francisco</creatorcontrib><title>Efficacy of systematic catheter locks solution of taurolidine/heparin versus taurolidine/urokinase in end-stage renal insufficiency stage 5D</title><title>Nefrología</title><addtitle>Nefrologia (Engl Ed)</addtitle><subject>Catheters</subject><subject>Heparin - adverse effects</subject><subject>Humans</subject><subject>Kidney Failure, Chronic - complications</subject><subject>Kidney Failure, Chronic - therapy</subject><subject>Urokinase-Type Plasminogen Activator</subject><issn>2013-2514</issn><issn>2013-2514</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9UcFu1TAQjCoQLYU_qFCOXJLaThzHFyRUWqhUiQucrbWzbv2aFz-8SaX3D3x0_ZpSwYXTrnZmd7QzRXHGWc0Z78439YQ-RawFE7xmoma8OSpORC6VkLx99Vd_XLwl2jDWSaHVm-K46bpOaylOit-X3gcHbl9GX9KeZtzCHFzpYL7DGVM5RndPJcVxmUOcDqwZlhTHMIQJz-9wBylM5QMmWugfKHf3YQLCMuM4DRXNcItlwgnGPKLlIBxwytIrIr-8K157GAnfP9fT4ufV5Y-Lb9XN96_XF59vKie6vqn6QXLEFqzqLVrLFCpsEcBZxpT3LXrZC1CaDcoyBz23LWfAMwI9QqOb0-J6vTtE2JhdCltIexMhmKdBTLcGUnZhROO6trFOci5Rts5rcE0jPdON8EorIfOtj-utXYq_FqTZbAM5HEeYMC5khOp6IUSv20xtV6pLkSihf5HmzBwyNRuzZmoOmRomTA4wr314VljsFoeXpT8hZsKnlYDZs4eAydCTsTiEhG7OT4X_KzwCFC24MA</recordid><startdate>202209</startdate><enddate>202209</enddate><creator>Fontseré, Néstor</creator><creator>Soriano, Alex</creator><creator>Mestres, Gaspar</creator><creator>Bermudez, Patricia</creator><creator>Zarco, Federico</creator><creator>Lozano, Valentín</creator><creator>Rodas, Lida</creator><creator>Broseta, Jose</creator><creator>Arias, Marta</creator><creator>Maduell, Francisco</creator><general>Elsevier España, S.L.U</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>DOA</scope></search><sort><creationdate>202209</creationdate><title>Efficacy of systematic catheter locks solution of taurolidine/heparin versus taurolidine/urokinase in end-stage renal insufficiency stage 5D</title><author>Fontseré, Néstor ; Soriano, Alex ; Mestres, Gaspar ; Bermudez, Patricia ; Zarco, Federico ; Lozano, Valentín ; Rodas, Lida ; Broseta, Jose ; Arias, Marta ; Maduell, Francisco</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2683-8d51ee4ab78bebb07e7e4eaacb007ff4ef582a790d7b0ca81b410a1ff4a8ea393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Catheters</topic><topic>Heparin - adverse effects</topic><topic>Humans</topic><topic>Kidney Failure, Chronic - complications</topic><topic>Kidney Failure, Chronic - therapy</topic><topic>Urokinase-Type Plasminogen Activator</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fontseré, Néstor</creatorcontrib><creatorcontrib>Soriano, Alex</creatorcontrib><creatorcontrib>Mestres, Gaspar</creatorcontrib><creatorcontrib>Bermudez, Patricia</creatorcontrib><creatorcontrib>Zarco, Federico</creatorcontrib><creatorcontrib>Lozano, Valentín</creatorcontrib><creatorcontrib>Rodas, Lida</creatorcontrib><creatorcontrib>Broseta, Jose</creatorcontrib><creatorcontrib>Arias, Marta</creatorcontrib><creatorcontrib>Maduell, Francisco</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Directory of Open Access Journals(OpenAccess)</collection><jtitle>Nefrología</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fontseré, Néstor</au><au>Soriano, Alex</au><au>Mestres, Gaspar</au><au>Bermudez, Patricia</au><au>Zarco, Federico</au><au>Lozano, Valentín</au><au>Rodas, Lida</au><au>Broseta, Jose</au><au>Arias, Marta</au><au>Maduell, Francisco</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy of systematic catheter locks solution of taurolidine/heparin versus taurolidine/urokinase in end-stage renal insufficiency stage 5D</atitle><jtitle>Nefrología</jtitle><addtitle>Nefrologia (Engl Ed)</addtitle><date>2022-09</date><risdate>2022</risdate><volume>42</volume><issue>5</issue><spage>611</spage><epage>613</epage><pages>611-613</pages><issn>2013-2514</issn><eissn>2013-2514</eissn><cop>Spain</cop><pub>Elsevier España, S.L.U</pub><pmid>36669952</pmid><doi>10.1016/j.nefroe.2021.02.013</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2013-2514
ispartof Nefrología, 2022-09, Vol.42 (5), p.611-613
issn 2013-2514
2013-2514
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_c643bc5115e54cf9ac335f0932f79725
source ScienceDirect Freedom Collection
subjects Catheters
Heparin - adverse effects
Humans
Kidney Failure, Chronic - complications
Kidney Failure, Chronic - therapy
Urokinase-Type Plasminogen Activator
title Efficacy of systematic catheter locks solution of taurolidine/heparin versus taurolidine/urokinase in end-stage renal insufficiency stage 5D
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T21%3A26%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20of%20systematic%20catheter%20locks%20solution%20of%20taurolidine/heparin%20versus%20taurolidine/urokinase%20in%20end-stage%20renal%20insufficiency%20stage%205D&rft.jtitle=Nefrolog%C3%ADa&rft.au=Fontser%C3%A9,%20N%C3%A9stor&rft.date=2022-09&rft.volume=42&rft.issue=5&rft.spage=611&rft.epage=613&rft.pages=611-613&rft.issn=2013-2514&rft.eissn=2013-2514&rft_id=info:doi/10.1016/j.nefroe.2021.02.013&rft_dat=%3Cproquest_doaj_%3E2768222894%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2683-8d51ee4ab78bebb07e7e4eaacb007ff4ef582a790d7b0ca81b410a1ff4a8ea393%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2768222894&rft_id=info:pmid/36669952&rfr_iscdi=true